Recent studies have shown that immunocompetent cells bear receptors of neuropeptides and neurotransmitters and that these ligands play roles in the immune response. In this study, the role of the sympathetic nervous system in host resistance against Listeria monocytogenes infection was investigated in mice pretreated with 6-hydroxydopamine (6-OHDA), which destroys sympathetic nerve termini. The norepinephrine contents of the plasma and spleens were significantly lower in 6-OHDA-treated mice than in vehicle-treated mice. The 50% lethal dose of L. monocytogenes was about 20 times higher for 6-OHDA-treated mice than for vehicletreated mice. Chemical sympathectomy by 6-OHDA upregulated interleukin-12 (IL-12) and tumor necrosis factor-alpha (TNF-␣) production in enriched dendritic cell cultures and gamma interferon (IFN-␥) and TNF-␣ production in spleen cell cultures, whereas chemical sympathectomy had no apparent effect on phagocytic activities, listericidal activities, and nitric oxide production in peritoneal exudate cells and splenic macrophages. Augmentation of host resistance against L. monocytogenes infection by 6-OHDA was abrogated in IFN-␥ ؊/؊ or TNF-␣ ؊/؊ mice, suggesting that upregulation of IFN-␥, IL-12, and TNF-␣ production may be involved in 6-OHDA-mediated augmentation of antilisterial resistance. Furthermore, adoptive transfer of spleen cells immune to L. monocytogenes from 6-OHDA-treated mice resulted in untreated naive recipients that had a high level of resistance against L. monocytogenes infection. These results suggest that the sympathetic nervous system may modulate host resistance against L. monocytogenes infection through regulation of production of IFN-␥, IL-12, and TNF-␣, which are critical in antilisterial resistance.
The nervous system and the immune system play important roles in the maintenance of homeostasis. Functional interactions between these two systems through humoral factors have been described previously (9, 44) . For example, lymphoid organs contain a rich supply of sympathetic nerve fibers (11) , and norepinephrine (NE) is synthesized and stored in the nerve termini (36, 51) . Once released, NE can stimulate either ␣-adrenergic or ␤-adrenergic receptors on effector cells. Adrenergic receptors are reportedly found on lymphocytes, granulocytes, monocytes, macrophages, and natural killer cells (2, 11, 20) . Recent studies demonstrated that T-helper 1 (Th1) clones and newly generated Th1 cells, but not Th2 clones or newly generated Th2 cells, express a ␤2-adrenergic receptor (35, 41) . Reciprocal regulation of NE and immune responses, including cytokine production, has been reported. It has been shown that cytokines produced by macrophages and lymphocytes, such as interleukin-1 (IL-1), IL-2, IL-6, and tumor necrosis factor alpha (TNF-␣), can inhibit NE release from presynaptic varicosities (3, 40, 43) . Conversely, NE reportedly inhibits production of cytokines, including IL-6, IL-10, gamma interferon (IFN-␥), and TNF-␣ (7, 49) , and prevents Th1 differentiation through selective suppression of IL-12 production (31) . However, a recent study indicated that NE promotes IL-12-mediated differentiation of naive CD4 ϩ T cells into Th1 effector cells, as well as IFN-␥ production by Th1 cells (22, 45) .
In previous studies to determine the role of the sympathetic nervous system in modulating immune responses in vivo, peripheral nerve terminals containing NE were reversibly destroyed in animals by chemical sympathectomy with the neurotoxin 6-hydroxydopamine (6-OHDA) before exposure to antigen. Experimental model systems in which 6-OHDAtreated animals have been used have yielded conflicting data for both cell-mediated immunity and antibody production; some studies have shown that primary and secondary cytolytic T-lymphocyte responses to herpes simplex virus (25) , delayed hypersensitivity to 2,4,6-trinitrochlorobenzene (27) , and proliferation of T and B cells (28) are reduced by 6-OHDA treatment, while other studies have demonstrated that the severity of Th1-driven experimental allergic encephalomyelitis (6) and the severity of experimental rheumatoid arthritis (10) are enhanced by chemical sympathectomy and that lymphocyte proliferation is increased by such treatment (26) . Moreover, 6-OHDA treatment has both increased (24) and decreased (21) the level of antibody production.
Host resistance against Listeria monocytogenes, a facultative intracellular pathogen, is controlled by cell-mediated immunity and is regulated by endogenous cytokines. IFN-␥ (4, 19) , TNF-␣ (16, 30, 34, 38) , IL-1 (17) , and IL-6 (23) reportedly play important roles in antilisterial resistance. Moreover, IL-12 is essential for differentiation of naive T cells into Th1 cells, which are dominantly induced in L. monocytogenes infections (18) . Recently, Alaniz et al. (1) reported that in mice which lack dopamine ␤-hydroxylase and which cannot produce NE and epinephrine, host resistance against L. monocytogenes infection is impaired. Our approach was to examine the effect of removal of the sympathetic nervous system input on host resistance against L. monocytogenes infection because denervation or exposure of a neurotransmitter such as NE may influence cytokine production, which regulates antilisterial resistance. We investigated the effect of 6-OHDA treatment on host resistance and cytokine responses in L. monocytogenes infection.
In this study, we demonstrated that blockage of the sympathetic nervous system input upregulates antilisterial resistance and that adaptive immunity might be enhanced by 6-OHDA treatment through upregulation of production of cytokines, such as TNF-␣, IFN-␥, and IL-12.
MATERIALS AND METHODS
Mice. Six-to eight-week-old C57BL/6 female mice were purchased from Clear Japan, Inc., Tokyo, Japan. Age-and sex-matched IFN-␥ Ϫ/Ϫ mice on a C57BL/6 ϫ Sv129 (48) and TNF-␣ Ϫ/Ϫ mice on a C57BL/6 ϫ Sv129 (49) were also used in some experiments. The mice were housed singly in small plastic cages under specific-pathogen-free conditions at the Institute for Animal Experiments, Hirosaki University School of Medicine. They were kept on a cycle consisting of 12 h of light and 12 h of darkness; the lights were turned on at 8:00 a.m. and off at 8:00 p.m. All experimental manipulations were carried out during the light portion of the cycle, generally between 9:00 a.m. and 3:00 p.m. The mice were allowed to acclimate to laboratory conditions for at least 2 weeks before experimental manipulation, and food and water were available at all times. This study was carried out in accordance with the Guidelines for Animal Experimentation of Hirosaki University.
6-OHDA treatment. 6-OHDA (Sigma Chemical Co., St. Louis, Mo.) was dissolved in sterile saline containing 0.01% L-ascorbic acid (Wako Pure Chemical Co., Osaka, Japan) as an antioxidant and was injected intraperitoneally at a concentration of 250 mg/kg (24) . Desipramine HCl (Sigma) was dissolved in a small volume of sterile water and then diluted with sterile saline. Desipramine was injected intraperitoneally at a concentration of 10 mg/kg 2 days before infection (24) .
Tissue sample preparation for high-performance liquid chromatography. Spleen homogenates (10%, wt/vol) in 0.1 M HClO 4 were prepared with a Dounce tissue grinder (Iwaki Glass, Tokyo, Japan) and then centrifuged at 11,000 ϫ g for 10 min at 4°C. Two hundred microliters of each sample was added to 1 ml of sodium phosphate buffer (pH 6.1) to which 50 mg of acid-washed alumina was added. One milliliter of 1.5 M Tris-EDTA (pH 8.6) was then added. The alumina was washed twice with distilled water and placed into an extraction chamber suspended over a centrifuge tube, and the distilled water was removed by centrifugation. The NE was then extracted by adding 200 l of 0.1 M HClO 4 to the alumina, vortexing, and then centrifuging the extraction medium into a new tube. Analysis by high-performance liquid chromatography was performed as described previously (12) .
Bacteria. L. monocytogenes 1b 1684 cells were prepared as described previously (31) . The concentration of washed cells was adjusted spectrophotometrically at 550 nm, and the cells were stored at Ϫ80°C until they were used. In most experiments, mice were infected intravenously with 0.1 50% lethal dose (LD 50 In vivo elimination of T-cell subsets. Hybridoma cell lines GK1.5 (anti-CD4; rat immuoglobulin G2b) and 53-6.72 (anti-CD8; rat immunoglobulin G2a) were used. The monoclonal antibodies (MAbs) in the ascites fluid were partially purified by (NH 4 ) 2 SO 4 precipitation. Mice were each given a single intravenous injection of 400 g of an MAb 1 day before L. monocytogenes infection (32) . Normal rat globulin was injected as a control for the MAbs. We confirmed that more than 95% of CD4 ϩ cells or CD8 ϩ cells were eliminated in the spleens and mesenteric lymph nodes of mice 24 h after injection of 400 g of the corresponding MAb by using flow cytometry, as reported previously (32) .
Adoptive transfer of spleen cells. Mice were infected with 0.1 LD 50 of L. monocytogenes on day 2 after injection of 6-OHDA or the vehicle (sterile saline containing L-ascorbic acid). Spleens were removed aseptically from mice on day 7 after infection, and splenocytes were obtained by squeezing the organs in RPMI 1640 medium (Nissui Pharmaceutical Co., Tokyo, Japan). Each cell suspension was filtered through stainless steel mesh (size 100). After lysis of erythrocytes, the cells were washed three times and resuspended in RPMI 1640 medium. Mice were each injected intravenously with 0. Spleen cell cultures. Spleen cells prepared as described above were resuspended in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS), 100 U of penicillin G per ml, and 100 g of streptomycin per ml and then placed in a 24-well tissue culture plate (Greiner, Frickenhausen, Germany) at a density of 10 6 cells/well in the presence of 10 7 HK-LM cells per well or 1 g of hamster anti-CD3-ε MAb 145-2C11 per well. After 24, 48, and 72 h of incubation at 37°C in a 5% CO 2 incubator, the supernatants were collected and stored at Ϫ80°C until the cytokine assays were performed.
Preparation of enriched DC. Dendritic cells (DC) were enriched from spleens as described previously (39) . Briefly, spleens were cut into small pieces and digested in 5 ml of RPMI 1640 medium-10% FCS containing 10 U of collagenase D (Boehringer, Mannheim, Germany) per ml for 60 min at 37°C in a 5% CO 2 incubator. After addition of 500 l of 1 mM EDTA in PBS, the cells were filtered through stainless steel mesh to remove the solid tissue and centrifuged at 300 ϫ g for 5 min at 4°C. The washed cells were resuspended in 3 ml of a 17% Optiprep (Nycomed Pharma, Oslo, Norway) solution diluted with Hanks' balanced salt solution, overlaid with 7 ml of 12% Optiprep (1.068 g/ml) and then with 3 ml of Hanks' balanced salt solution, and centrifuged at 600 ϫ g for 15 min at 20°C. The low-density cells at the interface between Hanks' balanced salt solution and 12% Optiprep were harvested and washed three times. These cells were then incubated with fluorescein isothiocyanate-labeled anti-CD11c MAb (PharMingen, San Francisco, Calif.) and analyzed with a FACSCalibur (Becton Dickinson, Mountain View, Calif.). More than 55% of the enriched cells expressed CD11c. Enriched DC suspended in RPMI 1640 medium supplemented with 10% FCS were placed in 96-well plates at a density of 10 5 cells/well in a final volume of 100 l. Then 10 6 HK-LM cells per well were added to each well. After 24 h of incubation, the supernatants were collected and stored at Ϫ80°C until the cytokine assays were performed.
Phagocytic and bactericidal assays. The phagocytic and listericidal activities of peritoneal exudate cells (PEC) and splenic macrophages were determined by the method described previously (30) . Splenic macrophages were prepared by adhering spleen cells twice in RPMI 1640 medium supplemented with 10% FCS in a petri dish for 1 h at 37°C in a 5% CO 2 incubator. To obtain PEC, mice were injected intraperitoneally with 2.5 ml of 10% proteose peptone (Difco) 2 days after vehicle or 6-OHDA treatment. Five days later, the peritoneal cavities were lavaged with RPMI 1640 medium, and PEC were washed with RPMI 1640 medium supplemented with 2% FCS three times. Splenic macrophages and PEC, which were resuspended in antibiotic-free RPMI 1640 medium supplemented with 10% fresh homologous serum at a concentration of 10 6 cells/ml, were mixed with 10 7 CFU of viable L. monocytogenes and incubated at 37°C for 30 min in a 5% CO 2 incubator. Then they were washed three times with RPMI 1640 medium supplemented with 5 g of gentamicin per ml to kill extracellular bacteria. The cells were resuspended in RPMI 1640 medium supplemented with 10% fresh homologous serum and 5 g of gentamicin per ml and were transferred into a 96-well flat-bottom microplate at a density of 10 6 cells in 100 l per well (Nunc, Roskilde, Denmark). The infected cells were lysed by treatment with RPMI 1640 medium containing 1% (wt/vol) CHAPS at zero time and 2, 4, and 6 h later. Lysates from three wells were pooled, and the number of viable intracellular bacteria in each specimen was determined by culturing on tryptic soy agar.
Cytokine assays. Titers of IFN-␥, TNF-␣, IL-4, IL-10, and IL-12p70 in the culture supernatants and organ extracts were determined by double-sandwich enzyme-linked immunosorbent assays as described previously (31) . Organ ex-tracts were prepared by centrifuging 10% (wt/vol) spleen and liver homogenates in RPMI 1640 medium containing 1% (wt/vol) CHAPS at 2,000 ϫ g for 20 min.
Measurement of nitrite concentration in culture supernatant. The nitrite concentration in a culture supernatant was assayed in a 96-well flat-bottom microplate by mixing 100 l of the culture supernatant with 100 l of Griess reagent (13) . The A 550 was measured 10 min later, and the concentration was determined by referring to a standard curve for 1 to 35 M sodium nitrate.
Statistical evaluation of the data. Data were expressed as means Ϯ standard deviations, and the Wilcoxon rank-sum test was used to determine the significance of the differences in bacterial counts in the organs and in cytokine titers between control and experimental groups.
RESULTS
Effect of 6-OHDA treatment on plasma and splenic NE content. The extent of denervation was verified by measuring plasma and splenic NE concentrations (Fig. 1) . A single intraperitoneal injection of 250 mg of 6-OHDA per kg resulted in significant decreases in plasma and splenic NE concentrations on day 2 after injection (P Ͻ 0.05). The significant decrease in splenic NE contents continued at least until day 8 after injection (data not shown).
Effect of 6-OHDA treatment on host resistance against L. monocytogenes infection. Mice were infected intravenously with 5 ϫ 10 5 , 5 ϫ 10 6 , or 5 ϫ 10 7 CFU of L. monocytogenes on day 2 after injection with 6-OHDA or the vehicle, and the survival of each group was observed for 10 days (Fig. 2A) . Fifty percent of the mice infected with 5 ϫ 10 5 CFU of L. monocytogenes in the vehicle-treated group died (data not shown). All of the mice infected with 5 ϫ 10 7 CFU of L. monocytogenes died within 4 days, in the 6-OHDA-treated group, whereas the mice infected with 5 ϫ 10 5 or 5 ϫ 10 6 CFU of L. monocytogenes survived. The LD 50 of L. monocytogenes for 6-OHDA-treated mice was about 20-fold higher than that for vehicle-treated mice. To confirm the effect of 6-OHDA treatment on bacterial growth in the organs, the numbers of bacterial cells in the spleens and livers of 6-OHDA-treated mice and vehicletreated mice were determined on days 2 and 5 postinfection (Fig. 2B) . The number of bacteria in the organs of 6-OHDAtreated mice were comparable to those in the organs of vehicle-treated mice on day 2 after infection, whereas bacterial growth in the spleens and livers of 6-OHDA-treated mice was significantly inhibited on day 5 after infection (P Ͻ 0.05).
Abrogation of the effect of 6-OHDA treatment on host resistance against L. monocytogenes infection by desipramine. To investigate whether the effect of 6-OHDA is drug specific, mice were injected with desipramine, which blocks the uptake of 6-OHDA into nerve fibers (24), before 6-OHDA injection. The numbers of L. monocytogenes CFU in the spleens and livers were determined on day 4 postinfection (Fig. 3) . The number of bacterial cells in the organs of 6-OHDA-treated mice was significantly less than the number of bacterial cells in the organs of vehicle-treated mice (P Ͻ 0.01), whereas bacterial growth was observed in the organs of 6-OHDA-treated mice when they had been treated with desipramine. Injection of desipramine alone had no effect on the number of bacteria. Effect of 6-OHDA treatment on cytokine production in spleen cell cultures. IFN-␥ and TNF-␣ are known to be critical factors in antilisterial resistance (4, 16, 19, 30, 34, 38) , and IL-4 reportedly plays a detrimental role in host defense (14) . We investigated production of cytokines, including IFN-␥, TNF-␣, and IL-4, in the spleen cell cultures obtained from vehicle-or 6-OHDA-treated mice. IFN-␥ production in 6-OHDA-treated mice was markedly enhanced when they were stimulated with anti-CD3 MAb (Fig. 4A) , whereas HK-LM-induced IFN-␥ production was only slightly enhanced (Fig. 4A) . Similarly, TNF-␣ production was increased by stimulation with HK-LM in 6-OHDA-treated spleen cells compared with vehicle-treated spleen cells (Fig. 4B) . IL-4 production induced by HK-LM or anti-CD3 MAb was also determined. There were no significant differences between the vehicle-treated group and the 6-OHDA-treated group. Stimulated with HK-LM, the vehicletreated mice produced 48 pg of IL-4 per ml and the 6-OHDAtreated mice produced 43 pg/ml; and stimulated with anti-CD3 MAb, the vehicle-treated mice produced 120 pg of IL-4 per ml and the 6-OHDA-treated mice produced 135 pg/ml.
Effect of 6-OHDA treatment on bacterial growth in cytokinedeficient mice. To examine the role of IFN-␥ and TNF-␣ in the augmentation of host resistance against L. monocytogenes infection by 6-OHDA treatment, IFN-␥ Ϫ/Ϫ or TNF-␣ Ϫ/Ϫ mice were injected with 6-OHDA or the vehicle, and they were each infected with 0.1 LD 50 of L. monocytogenes. The numbers of viable bacteria in the organs were determined on day 4 after infection. The numbers of bacteria in the spleens and livers of 6-OHDA-treated IFN-␥ Ϫ/Ϫ or TNF-␣ Ϫ/Ϫ mice were comparable to the numbers of bacteria in the spleens and livers of vehicle-treated mice (Fig. 5) .
Effect of 6-OHDA treatment on phagocytic and bactericidal activities of macrophages. We investigated whether 6-OHDA treatment affects the phagocytic and listericidal activities of splenic macrophages and PEC in vitro. The drug treatment had no effect on the phagocytic activities of splenic macrophages (vehicle-treated mice, 2.47 ϫ 10 5 CFU/10 5 cells; 6-OHDA-treated mice, 2.63 ϫ 10 5 CFU/10 5 cells). Similar results were obtained for phagocytosis by PEC (vehicle-treated mice, 1.79 ϫ 10 6 CFU/10 5 cells; 6-OHDA-treated mice, 1.39 ϫ 10 6 CFU/10 5 cells). Next, the listericidal activities of splenic macrophages and PEC obtained from 6-OHDA-treated mice or vehicle-treated mice were determined 2, 4, and 6 h after phagocytosis. The numbers of viable bacteria in the splenic macrophages and PEC obtained from 6-OHDA-treated mice were comparable the numbers obtained for vehicle-treated mice (Fig. 6A) . We also examined the effect of chemical sympathectomy on nitric oxide production by L. monocytogenesinfected PEC and splenic macrophages, and we found that (Fig. 6B) . Similar results were obtained when splenic macrophages were used (Fig. 6B) . Effect of 6-OHDA treatment on cytokine production in DC cultures. It is known that cytokines, such as IL-12 produced by DC, are critical in Th1 differentiation (5) . Therefore, the effect of 6-OHDA treatment on cytokine production by DC was investigated. Mice were infected with 5 ϫ 10 4 CFU of L. monocytogenes on day 2 after injection of 6-OHDA or the vehicle. For each group five spleens were removed from the mice 24 h after infection, and DC were enriched. The enriched DC were cultured for 24 h in the presence of HK-LM, and the levels of cytokines, including IL-12p70, TNF-␣, and IL-10, in the supernatants were measured. The titers of IL-12 and TNF-␣ produced by DC from 6-OHDA-treated mice were higher than the titers of these cytokines produced by DC from vehicle-treated mice (Fig. 7) (P Ͻ 0.05). IL-10 could not be detected in these cultures.
Role of T-cell subsets on host resistance against L. monocytogenes infection in 6-OHDA-treated mice. To examine the effect of 6-OHDA on T-cell-dependent antilisterial resistance, CD4 ϩ or CD8 ϩ cells were depleted by injecting the corresponding MAbs into 6-OHDA-or vehicle-treated mice. When mice were pretreated with the vehicle, the numbers of bacteria in the spleens of CD8 ϩ cell-depleted mice, but not in the spleens of CD4 ϩ cell-depleted mice, were significantly higher than the numbers of bacteria in the spleens of normal rat globulin-treated mice 5 days postinfection (Fig. 8A ) (P Ͻ 0.05). Similar results were obtained when mice were denerved with 6-OHDA (Fig. 8B) . spleens and livers were determined 48 postinfection. There were no significant differences in bacterial growth in this case (Fig. 9B) .
DISCUSSION
The results obtained by using mice that were chemically sympathectomized with 6-OHDA demonstrated that the sympathetic nervous system may downregulate host resistance against L. monocytogenes. It was assumed that the sympathetic nervous system might be involved in regulation of production of IFN-␥, IL-12, and TNF-␣, which are critical in antilisterial resistance.
6-OHDA reportedly destroys noradrenergic nerve termini in the peripheral nervous system (52) . In the present study, a single injection of 6-OHDA significantly decreased the NE contents of the plasma and spleens (Fig. 1) , and the splenic NE contents continued to decrease significantly until at least day 8 after injection (data not shown).
The present study also showed that 6-OHDA treatment enhanced host resistance against L. monocytogenes infection; 6-OHDA-treated mice were able to survive after infection with lethal doses of L. monocytogenes (Fig. 2A) . The LD 50 of L. monocytogenes for 6-OHDA-treated mice was about 20-fold higher than that for vehicle-treated mice. 6-OHDA treatment had no significant effect on bacterial growth in the spleens and livers of mice at 6 h (data not shown) or day 2 (Fig. 2B) postinfection. Innate immunity due to macrophages and neutrophils occurs at this stage (48) . The results also demonstrated that the phagocytic activities, listericidal activities, and nitric oxide production in PEC and splenic macrophages from the drug-treated mice were comparable to those in PEC and splenic macrophages from the vehicle-treated mice (Fig. 6) . In contrast, late in infection bacterial growth in the organs of 6-OHDA-treated mice was significantly inhibited compared with bacterial growth in the organs of vehicle-treated mice (Fig. 2B) ; in the latter mice L. monocytogenes was eliminated from the organs of infected animals by T-cell-dependent mechanisms (48) . Treatment with desipramine, which blocks the uptake of 6-OHDA into the nerve fibers and subsequent nerve destruction (23) , prevented an increase in elimination of L. monocytogenes from the organs of 6-OHDA-treated mice (Fig.  3) , suggesting that enhancement of antilisterial resistance by 6-OHDA might be drug specific.
TNF-␣ has been recognized as a critical factor in host resistance against L. monocytogenes infection due to activating macrophages and neutrophils (16, 30, 34, 38, 48) . It has been reported that chemical sympathectomy by 6-OHDA upregulates production of cytokines, such as IFN-␥, IL-1␤, IL-2, IL-4, and IL-6 (8, 24, 28) . Moreover, NE reportedly inhibits production of IFN-␥, IL-1␤, IL-6, and TNF-␣ (14, 35, 41, 42, 49) . Our results also showed that TNF-␣ production increased in both splenocytes ( Fig. 4B) and DC (Fig. 7B ) stimulated with HK-LM in 6-OHDA-treated mice. CD8
ϩ T cells are known to play a critical role in elimination of L. monocytogenes from the organs of mice (15) . In this study, a CD8 ϩ T-cell-mediated mechanism enhanced antilisterial resistance by chemical sympathectomy because depletion of CD8 ϩ cells abrogated the resistance (Fig. 8) . Recent studies demonstrated that TNF-␣ is required for CD8 ϩ T-cell-mediated antilisterial immunity (15, 50) . The effect of 6-OHDA on bacterial growth in the organs was not observed with TNF-␣ Ϫ/Ϫ mice (Fig. 5 ). These findings suggest that upregulation of TNF-␣ production is involved in 6-OHDA-mediated augmentation of antilisterial resistance.
L. monocytogenes induces a Th1 response in the host (18) , and IFN-␥ plays a critical role in antilisterial resistance (4, 19) . In this study, IFN-␥ production was enhanced when spleen cells were stimulated with anti-CD3 MAb (Fig. 4A) , indicating that the ability of T cells to produce IFN-␥ may be increased by chemical sympathectomy. No effect of 6-OHDA on bacterial growth in the organs of IFN-␥ Ϫ/Ϫ mice was observed (Fig. 5) , suggesting that upregulation of IFN-␥ production is also involved in 6-OHDA-mediated augmentation of antilisterial resistance. Alternatively, IL-4 is known to suppress antilisterial resistance (15) , assuming that downregulation of IL-4 production may be involved in the resistance enhanced by chemical sympathectomy. However, the IL-4 production in 6-OHDAtreated mice was comparable to that in vehicle-treated mice.
Priming of naive T cells results from encounters with professional antigen-containing cells, such as DC. A recent study showed that NE controls DC migration from the site of inflammation to regional lymph nodes through an ␣ 1b -adrenergic receptor (29) . Alternatively, it is known that cytokines, such as IL-12 produced by DC, are critical in Th1 differentiation (5) . Our study demonstrated that more IL-12 was produced in response to HK-LM by splenic DC from 6-OHDA-treated mice than by splenic DC from vehicle-treated mice (Fig. 7A) . Penina-Bordignon et al. (33) reported that ␤ 2 -adrenergic receptor agonists prevented Th1 development by selective inhibition of IL-12. These finding suggest that upregulation of IL-12 production by DC, in addition to upregulation of TNF-␣ and IFN-␥ production, may be involved in 6-OHDA-mediated augmentation of antilisterial resistance. The present study showed that 6-OHDA treatment enhanced antilisterial activity late in infection (Fig. 2B) , when L. monocytogenes is eliminated from the organs of infected animals by T-cell-dependent mechanisms (48) . To address whether induction of adaptive immunity to L. monocytogenes infection is enhanced by chemical sympathectomy or denervation is required for expression of augmented antilisterial resistance, we investigated adoptive transfer of splenocytes immune to L. monocytogenes between 6-OHDA-or vehicle-treated donors and recipients (Fig. 9) . Inhibition of bacterial growth was significantly enhanced in the organs of mice when immune spleen cells obtained from 6-OHDA-treated mice were transferred, while there were no significant differences in bacterial growth when spleen cells that were immune to L. monocytogenes and were obtained from untreated mice were transferred to 6-OHDA-treated or vehicle-treated mice. These results suggest that chemical sympathectomy might augment induction of adaptive immunity.
In contrast to our results, Alaniz et al. (1) reported that mice lacking dopamine ␤-hydroxylase, which cannot produce NE and epinephrine, exhibited impaired host resistance against L. monocytogenes infection and that production of IFN-␥ and TNF-␣ by spleen cells was decreased in these animals. Although we cannot explain the discrepancy, there was a clear difference between the two systems in terms of NE content; the mutant mice lacked NE completely, and NE release in 6-OHDA-treated mice was partially inhibited. Alternatively, 6-OHDA destroys noradrenergic nerve termini only in the peripheral nervous system because the drug does not cross the blood-brain barrier (52) , while dopamine ␤-hydroxylase-deficient mice lack NE in their whole bodies, including their brains (1) . On the other hand, Rice et al. (37) recently reported that antilisterial resistance was enhanced by 6-OHDA pretreatment, which is consistent with our results. These authors also indicated that IFN-␥ production induced by HK-LM was lower in spleen cell cultures obtained from 6-OHDA-treated mice on day 7 after infection but not on day 5 or 9 after infection. In our study, the levels of IFN-␥ production induced by HK-LM in spleen cell cultures were comparable in 6-OHDA-and vehicletreated mice before infection (Fig. 4) and on day 2 after infection (data not shown), but IFN-␥ production was not investigated on day 7 after infection.
Recent studies demonstrated that Th1 clones and newly generated Th1 cells, but not Th2 clones or newly generated Th2 cells, express a ␤ 2 -adrenergic receptor (10, 41) . Reciprocal regulation of NE and immune responses, including differentiation of T cells and B cells and cytokine production, has been reported. Studies are being planned to clarify the precise mechanism of interaction between the sympathetic nervous system and antilisterial resistance through the roles of adrenergic receptor expressed in immunocompetent cells. IFN-␥ production induced by HK-LM was lower in spleen cell cultures.
